Patent Assignment
Reel/Frame 038249/0590
Assignment of Assignor's Interest
Recorded: 2016-03-24
Pages: 7
Assignor
BORODIC, GARY E, DR
Executed: 2016-03-23
Assignee
BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
1261 FURNACE BROOK PARKWAY, QUINCY, MASSACHUSETTS, 02169
Covered Properties
(27)
Controlled Administration of Chemodenervating Pharmaceuticals
Patent:
5,298,019 →
Application:
08/004,090 →
Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseases
Application:
10/212,657 →
Publication:
US 2002/0187164
Methods of Using Botulinum Toxin for the Treatment of Hypervolemic Lip Deformity (Lip Ectropion)
Treatment of Chronic Chalazion and Hordeolum with Botulinum Toxin
Anti-Inflammatory Topical Botulinum Toxin Composition
Application:
12/318,572 →
Publication:
US 2009/0148476
High-Potency Botulinum Toxin Formulations
High-Potency Botulinum Toxin Formulations
Application:
14/225,011 →
Publication:
US 2014/0315820
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
14/464,740 →
Publication:
US 2016/0051643
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
14/555,870 →
Publication:
US 2015/0086533
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
14/573,659 →
Publication:
US 2015/0132283
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
14/753,917 →
Publication:
US 2015/0297688
Extended Length Botulinum Toxin Formulation for Human or Mammalian Use
Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
New composition of the therapeutic and cosmetic botulinum toxin
Application:
60/383,570 →
Enhanced sequestration (molecular anchor) of therapeutic botulinum using increased amounts of albumin excipient
Application:
60/435,901 →
Treatment of chronic chalazion and hordeolum with botulinum toxin injections
Application:
60/453,029 →
Treatment of sinusitis related chronic facial pain and headache with botulinum toxin injections
Application:
60/453,037 →
Use of Botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion)
Application:
60/534,330 →
Botulinum toxin and the treatment of depressive, anxiety and sleep disorders
Application:
60/690,162 →
Botulinum toxin and the treatment of primary disorders of mood and effect
Application:
60/693,771 →
Botulinum toxin and the treatment of depressive, anxiety and sleep disorders
Application:
60/721,060 →
Botulinum toxin based pharmaceutical compositions
Application:
60/724,913 →
Botulinum toxin and the treatment of primary disorders of mood and affect
Application:
60/738,981 →
Extended length botulinum toxin formulation for human or mammalian use
Application:
61/193,513 →
Use of Botulinum Toxin for the Treatment of Cerebrovascular Disease, renovascular and retinovascular circulatory beds
Application:
61/623,087 →
Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
Application:
62/026,093 →
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 11, 1995
From: ASSOCIATED SYNAPSE BIOLOGICS
To: INTERACTIVE BIOLOGICS ASSOCIATES
Reel/Frame 007570/0331 →
Assignment of Assignor's Interest
Aug 14, 1995
From: ASSOCIATED SYNAPSE BIOLOGICS
To: INTERACTIVE BIOLOGICS ASSOCIATES
Reel/Frame 007613/0232 →
Assignment of Assignor's Interest
Feb 7, 2000
From: INTERACTIVE BIOLOGICS ASSOCIATES
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 010579/0813 →
Assignment of Assignor's Interest
Mar 24, 2016
From: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
To: BORODIC, GARY E.
Reel/Frame 038096/0402 →
Assignment of Assignor's Interest
Jun 3, 2016
From: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 038870/0160 →
Security Interest
Mar 18, 2022
From: REVANCE THERAPEUTICS, INC.
To: ATHYRIUM BUFFALO LP
Reel/Frame 059437/0654 →
Security Interest
Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; BELLUS MEDICAL, LLC; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0736 →
Security Interest
Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0663 →
Release of Security Interest
Feb 7, 2025
From: ATHYRIUM BUFFALO LP
To: REVANCE THERAPEUTICS, INC
Reel/Frame 070153/0630 →
Security Interest
Feb 17, 2025
From: REVANCE THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 070239/0739 →